EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Use of estimands in cluster randomised trials: A review

Dongquan Bi iD, Andrew Copas iD, Brennan C Kahan iD

Clinical Trials · 2026

DOI: 10.1177/17407745251415538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Trials, 2026. Verfasst von Dongquan Bi und 2 weiteren Autor:innen. Beteiligte Einrichtung: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An estimand is a clear description of the treatment effect a study aims to quantify. The ICH E9(R1) addendum lists five attributes that should be described as part of the estimand definition. However, the addendum was primarily developed for individually randomised trials. Cluster randomised trials, in which groups of individuals are randomised, have additional considerations for defining estimands (e.g. how individuals and clusters are weighted, how cluster-level intercurrent events are handled). However, it is currently unknown if estimands are being used in cluster randomised trials, or whether the considerations specific to cluster randomised trials are being described.

Methods

We reviewed 73 cluster randomised trials published between October 2023 and January 2024 that were indexed in MEDLINE. For each trial, we assessed whether the estimand for the primary outcome was described, or if not, whether it could be inferred from the statistical methods. We also assessed whether considerations specific to cluster randomised trials were described or inferable, how trials were analysed and whether key assumptions being made in the analysis (e.g. ‘no informative cluster size’) could be identified.

Results

No trials attempted to describe the estimand for their primary outcome. We were able to infer the five attributes outlined in ICH E9(R1) in only 49% of trials, and when including additional considerations specific to cluster randomised trials, this figure dropped to 21%. Key drivers of this ambiguity were lack of clarity around whether individual- or cluster-average effects were of interest (unclear in 63% of trials), and how cluster-level intercurrent events were handled (unclear in 21% of trials for which this was applicable). Over half of trials used mixed-effects models or generalising estimating equations with an exchangeable correlation structure, which make the assumption that there is no informative cluster size; however, only one of these trials performed sensitivity analyses to evaluate robustness of results to deviations from this assumption. There were 14% of trials that used independence estimating equations or the analysis of cluster-level summaries; however, because no trials stated whether they were targeting the individual- or cluster-average effect, it was impossible to determine whether these methods implemented the appropriate weighting scheme and were thus unbiased.

Conclusion

The uptake of estimands in published cluster randomised trial articles is low, making it difficult to ascertain which questions were being investigated or whether statistical estimators were appropriate for those questions. This highlights an urgent need to develop guidelines on defining estimands that cover unique aspects of cluster randomised trials to ensure clarity of research questions in these trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignHumansCluster AnalysisData Interpretation, Statistical

Stichwörter der Autor:innen

EstimandICH E9(R1)cluster randomised trialintercurrent event

Autor:innen und Institutionen

  • MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.

ORCID-Profile: Dongquan Bi, Andrew Copas, Brennan C Kahan

Förderung

  • Medical Research Council

Zitieren

APA

Bi, D., Copas, A., & Kahan, B. C. (2026). Use of estimands in cluster randomised trials: A review. Clinical Trials. https://doi.org/10.1177/17407745251415538

Vancouver

Bi D, Copas A, Kahan BC. Use of estimands in cluster randomised trials: A review. Clinical Trials. 2026. doi:10.1177/17407745251415538

BibTeX
@article{Bi2026,
  author = {Bi, Dongquan and Copas, Andrew and Kahan, Brennan C},
  title = {Use of estimands in cluster randomised trials: A review},
  journal = {Clinical Trials},
  year = {2026},
  doi = {10.1177/17407745251415538}
}
Kostenlos starten →